fercelan kõvakapsel
g.l. pharma gmbh - raud(ii)fumaraat+foolhape+askorbiinhape - kõvakapsel - 202,8mg+0,8mg+100mg 100tk; 202,8mg+0,8mg+100mg 30tk; 202,8mg+0,8mg+100mg 56tk; 202,8mg+0,8mg+100mg 84tk; 202,8mg+0,8mg+100mg 28tk; 202,8mg+0,8mg+100mg 98tk; 202,8mg+0,8mg+100mg 20tk; 202,8mg+0,8mg+100mg 60tk
prokanazol kõvakapsel
pro.med.cs praha a.s. - itrakonasool - kõvakapsel - 100mg 18tk; 100mg 28tk; 100mg 14tk; 100mg 30tk
caspofungin teva infusioonilahuse kontsentraadi pulber
teva b.v. - kaspofungiin - infusioonilahuse kontsentraadi pulber - 70mg 10ml 1tk
caspofungin sandoz infusioonilahuse kontsentraadi pulber
sandoz pharmaceuticals d.d. - kaspofungiin - infusioonilahuse kontsentraadi pulber - 70mg 10ml 1tk
caspofungin sandoz infusioonilahuse kontsentraadi pulber
sandoz pharmaceuticals d.d. - kaspofungiin - infusioonilahuse kontsentraadi pulber - 50mg 10ml 1tk
caspofungin teva generics infusioonilahuse kontsentraadi pulber
teva b.v. - kaspofungiin - infusioonilahuse kontsentraadi pulber - 50mg 1tk
caspofungin teva infusioonilahuse kontsentraadi pulber
teva b.v. - kaspofungiin - infusioonilahuse kontsentraadi pulber - 50mg 10ml 1tk
caspofungin teva generics infusioonilahuse kontsentraadi pulber
teva b.v. - kaspofungiin - infusioonilahuse kontsentraadi pulber - 70mg 1tk
calquence
astrazeneca ab - acalabrutinib - leukeemia, lümfotsüütne, krooniline, b-rakk - antineoplastic agents, protein kinase inhibitors, - calquence as monotherapy or in combination with obinutuzumab is indicated for the treatment of adult patients with previously untreated chronic lymphocytic leukaemia (cll). calquence as monotherapy is indicated for the treatment of adult patients with chronic lymphocytic leukaemia (cll) who have received at least one prior therapy.
epysqli
samsung bioepis nl b.v. - eculizumab - hemoglobinuuria, paroksüsmaalne - immunosupressandid - epysqli is indicated in adults and children for the treatment of paroxysmal nocturnal haemoglobinuria (pnh). evidence of clinical benefit is demonstrated in patients with haemolysis with clinical symptom(s) indicative of high disease activity, regardless of transfusion history.